EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The ALX1 transcription factor acts in the early cranial mesoderm to specify extraocular muscle formation

Paul P R Iyyanar iD, Nirpesh Adhikari, Yu Lan iD, Rulang Jiang iD

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Paul P R Iyyanar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Hauptthemen laut MEDLINE: Mesoderm, Muscle Development, Oculomotor Muscles, Skull. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cincinnati Children's Hospital Medical Center, Core, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss of ALX1 gene function causes severe facial clefting and extreme microphthalmia. Previous studies suggest that ALX1 protein function is crucial for patterning the cranial neural crest cell (CNCC)-derived frontonasal mesenchyme, but how ALX1 regulates eye development is not well understood. Here, we show that Alx1 is transiently expressed in the embryonic cranial mesoderm and that Alx1−/− mice exhibit agenesis of extraocular muscles (EOMs) without affecting other muscles. We show that cranial mesoderm-specific Alx1 inactivation resulted in complete EOM agenesis accompanied by failure of activation of the core myogenic regulatory network specifically in, and increased apoptosis of, the EOM progenitor cells. Analysis of mice with temporally induced Alx1 inactivation demonstrated that EOM myogenesis requires Alx1 function before, but not after, formation of the EOM primordium. These data identify ALX1 as a unique and specific upstream regulator of EOM myogenesis, and provide new insights into pathogenic mechanisms underlying ALX1-type frontonasal dysplasia, as well as molecular mechanisms controlling cell fate specification in the early cranial mesoderm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MesodermMuscle DevelopmentOculomotor MusclesSkullTranscription FactorsHomeodomain ProteinsAnimalsGene Expression Regulation, DevelopmentalApoptosisMiceNeural CrestEmbryo, MammalianMice, KnockoutStem Cells

Stichwörter der Autor:innen

CraniofacialEyeFrontonasal dysplasiaHomeodomainMesodermMyogenesisNeural crest

Substanzen

Transcription FactorsHomeodomain Proteins

Autor:innen und Institutionen

  • Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Division of Plastic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Departments of Pediatrics and Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.

ORCID-Profile: Paul P R Iyyanar, Yu Lan, Rulang Jiang

Förderung

  • Cincinnati Children's Hospital Medical Center
  • Core
  • NIDCR NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Iyyanar, P. P. R., Adhikari, N., Lan, Y., & Jiang, R. (2026). The ALX1 transcription factor acts in the early cranial mesoderm to specify extraocular muscle formation. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052241

Vancouver

Iyyanar PPR, Adhikari N, Lan Y, Jiang R. The ALX1 transcription factor acts in the early cranial mesoderm to specify extraocular muscle formation. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052241

BibTeX
@article{Iyyanar2026,
  author = {Iyyanar, Paul P R and Adhikari, Nirpesh and Lan, Yu and Jiang, Rulang},
  title = {The ALX1 transcription factor acts in the early cranial mesoderm to specify extraocular muscle formation},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052241}
}
Kostenlos starten →